|
1
|
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.
|
Neurourol Urodyn
|
2002
|
22.80
|
|
2
|
Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.
|
Neurourol Urodyn
|
2002
|
8.01
|
|
3
|
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.
|
Eur Urol
|
2006
|
7.13
|
|
4
|
ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence.
|
Neurourol Urodyn
|
2004
|
5.31
|
|
5
|
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.
|
Am J Obstet Gynecol
|
2002
|
4.31
|
|
6
|
Urodynamic features and artefacts.
|
Neurourol Urodyn
|
2012
|
3.78
|
|
7
|
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction.
|
BJU Int
|
2011
|
3.28
|
|
8
|
Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
|
Eur Urol
|
2008
|
2.58
|
|
9
|
The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society.
|
Neurourol Urodyn
|
2002
|
2.46
|
|
10
|
Symptom bother and health care-seeking behavior among individuals with overactive bladder.
|
Eur Urol
|
2008
|
2.41
|
|
11
|
Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
|
Eur Urol
|
2009
|
2.33
|
|
12
|
A new classification is needed for pelvic pain syndromes--are existing terminologies of spurious diagnostic authority bad for patients?
|
J Urol
|
2006
|
2.13
|
|
13
|
EAU guidelines on urinary incontinence.
|
Eur Urol
|
2010
|
2.10
|
|
14
|
The immediate and 6-mo reproducibility of pressure-flow studies in men with benign prostatic enlargement.
|
Eur Urol
|
2007
|
2.03
|
|
15
|
A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis.
|
Eur Urol
|
2012
|
1.81
|
|
16
|
Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 2: Noninvasive urodynamics and combination of measures.
|
J Urol
|
2006
|
1.77
|
|
17
|
The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder.
|
Eur Urol
|
2006
|
1.77
|
|
18
|
How should patients with an overactive bladder manipulate their fluid intake?
|
BJU Int
|
2008
|
1.70
|
|
19
|
Ultrasound estimated bladder weight and measurement of bladder wall thickness--useful noninvasive methods for assessing the lower urinary tract?
|
J Urol
|
2010
|
1.67
|
|
20
|
Lower urinary tract symptoms revisited: a broader clinical perspective.
|
Eur Urol
|
2008
|
1.62
|
|
21
|
Noninvasive techniques for the measurement of isovolumetric bladder pressure.
|
J Urol
|
2004
|
1.58
|
|
22
|
Risk of tape-related complications after TVT is at least 4%.
|
Neurourol Urodyn
|
2010
|
1.52
|
|
23
|
Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries.
|
BJU Int
|
2006
|
1.50
|
|
24
|
The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence.
|
BJOG
|
2002
|
1.50
|
|
25
|
Validity of the international consultation on incontinence questionnaire-pediatric lower urinary tract symptoms: a screening questionnaire for children.
|
J Urol
|
2010
|
1.48
|
|
26
|
Automatic evaluation of ultrasonography-estimated bladder weight and bladder wall thickness in community-dwelling men with presumably normal bladder function.
|
BJU Int
|
2011
|
1.45
|
|
27
|
Can maximum urethral closure pressure (MUCP) be used to predict outcome of surgical treatment of stress urinary incontinence?
|
Neurourol Urodyn
|
2011
|
1.44
|
|
28
|
What patients think: patient-reported outcomes of retropubic versus trans-obturator mid-urethral slings for urodynamic stress incontinence--a multi-centre randomised controlled trial.
|
Int Urogynecol J
|
2011
|
1.41
|
|
29
|
Flow meter urine testing: a practical proposition in patients attending for urodynamics?
|
BJU Int
|
2006
|
1.40
|
|
30
|
The efficacy and safety of PSD503 (phenylephrine 20%, w/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study.
|
Eur J Obstet Gynecol Reprod Biol
|
2011
|
1.39
|
|
31
|
Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.
|
Neurourol Urodyn
|
2008
|
1.26
|
|
32
|
Could the National Institute for Health and Clinical Excellence guidelines on urodynamics in urinary incontinence put some women at risk of a bad outcome from stress incontinence surgery?
|
BJU Int
|
2008
|
1.24
|
|
33
|
Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
|
BJOG
|
2004
|
1.24
|
|
34
|
Overactive bladder and painful bladder syndrome: there need not be confusion.
|
Neurourol Urodyn
|
2005
|
1.23
|
|
35
|
A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence.
|
Am J Obstet Gynecol
|
2004
|
1.23
|
|
36
|
Surgical treatment of stress incontinence in men.
|
Neurourol Urodyn
|
2010
|
1.23
|
|
37
|
Urogenital pain--time to accept a new approach to phenotyping and, as a consequence, management.
|
Eur Urol
|
2007
|
1.19
|
|
38
|
A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder.
|
BJU Int
|
2005
|
1.13
|
|
39
|
Understanding the elements of overactive bladder: questions raised by the EPIC study.
|
BJU Int
|
2008
|
1.12
|
|
40
|
Editorial comment: Re: Brubaker L. Conflict of interest: what is the role of our professional societies? Neurourol Urodyn 2012;31:1217-1218.
|
Neurourol Urodyn
|
2012
|
1.08
|
|
41
|
Overactive bladder: an update.
|
Curr Opin Urol
|
2007
|
1.08
|
|
42
|
Development and validation of a quality-of-life measure for men with nocturia.
|
Urology
|
2004
|
1.07
|
|
43
|
Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial.
|
BMJ
|
2002
|
1.06
|
|
44
|
Access to every trial dataset is crucial.
|
BMJ
|
2004
|
1.06
|
|
45
|
Suprapubic catheter insertion is an outpatient procedure: cost savings resultant on closing an audit loop.
|
BJU Int
|
2008
|
1.05
|
|
46
|
The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction.
|
J Urol
|
2005
|
1.03
|
|
47
|
Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1: Nonurodynamic approach.
|
J Urol
|
2006
|
1.03
|
|
48
|
The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated bladder outlet obstruction.
|
BJU Int
|
2005
|
1.00
|
|
49
|
Technique of urethral retro-resistance pressure measurement.
|
Neurourol Urodyn
|
2004
|
1.00
|
|
50
|
Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men.
|
J Sex Med
|
2008
|
0.95
|
|
51
|
What are the causes and consequences of bladder overdistension? ICI-RS 2011.
|
Neurourol Urodyn
|
2012
|
0.95
|
|
52
|
Persistent detrusor overactivity after transurethral resection of the prostate.
|
Curr Urol Rep
|
2008
|
0.95
|
|
53
|
Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.
|
Drugs
|
2004
|
0.94
|
|
54
|
The extent and severity of urinary incontinence amongst women in UK GP waiting rooms.
|
Fam Pract
|
2006
|
0.93
|
|
55
|
Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence.
|
BJU Int
|
2006
|
0.92
|
|
56
|
Can we prevent incontinence? ICI-RS 2011.
|
Neurourol Urodyn
|
2012
|
0.91
|
|
57
|
A patient-centered approach to developing a comprehensive symptom and quality of life assessment of anal incontinence.
|
Dis Colon Rectum
|
2007
|
0.90
|
|
58
|
The natural history of the overactive bladder and detrusor overactivity. A review of the evidence regarding the long-term outcome of the overactive bladder.
|
J Urol
|
2003
|
0.90
|
|
59
|
Benign prostatic hyperplasia: The term BPH is misused.
|
BMJ
|
2008
|
0.89
|
|
60
|
Natural history of detrusor contractility--minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor.
|
Scand J Urol Nephrol Suppl
|
2004
|
0.89
|
|
61
|
Psychometric evaluation of a new patient-completed questionnaire for evaluating anal incontinence symptoms and impact on quality of life: the ICIQ-B.
|
Dis Colon Rectum
|
2011
|
0.88
|
|
62
|
Cure sometimes, help always--a "continence paradigm" for all ages and conditions.
|
Neurourol Urodyn
|
2006
|
0.88
|
|
63
|
Does the patient's position influence the detection of detrusor overactivity?
|
Neurourol Urodyn
|
2008
|
0.88
|
|
64
|
Efficacy and tolerability of tolterodine extended release in male and female patients with overactive bladder.
|
Eur Urol
|
2006
|
0.86
|
|
65
|
Urinary diaries: evidence for the development and validation of diary content, format, and duration.
|
Neurourol Urodyn
|
2011
|
0.86
|
|
66
|
Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
|
Neurourol Urodyn
|
2008
|
0.85
|
|
67
|
The 50-year history of the ice water test in urology.
|
J Urol
|
2010
|
0.85
|
|
68
|
Defining achievable standards in urodynamics-a prospective study of initial resting pressures.
|
Neurourol Urodyn
|
2012
|
0.83
|
|
69
|
Recognition and effective management of autonomic dysreflexia in spinal cord injuries.
|
Expert Opin Pharmacother
|
2007
|
0.83
|
|
70
|
Impact of surgical treatment on nocturia in men with benign prostatic obstruction.
|
BJU Int
|
2006
|
0.83
|
|
71
|
Transurethral prostate resection, noncontact laser therapy or conservative management in men with symptoms of benign prostatic enlargement? An economic evaluation.
|
J Urol
|
2002
|
0.83
|
|
72
|
Desmopressin, as a "designer-drug," in the treatment of overactive bladder syndrome.
|
Neurourol Urodyn
|
2009
|
0.82
|
|
73
|
Nocturia: new directions.
|
Neurourol Urodyn
|
2011
|
0.81
|
|
74
|
The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated detrusor underactivity.
|
BJU Int
|
2005
|
0.81
|
|
75
|
Lower urinary tract symptom: still too much focus on the prostate?
|
Curr Opin Urol
|
2014
|
0.80
|
|
76
|
Re: Update on AUA guideline on the management of benign prostatic hyperplasia: K. T. McVary, C. G. Roehrborn, A. L. Avins, M. J. Barry, R. C. Bruskewitz, R. F. Donnell, H. E. Foster, Jr., C. M. Gonzalez, S. A. Kaplan, D. F. Penson, J. C. Ulchaker and J. T. Wei J Urol 2011; 185: 1793-1803.
|
J Urol
|
2011
|
0.80
|
|
77
|
Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration.
|
BJU Int
|
2010
|
0.80
|
|
78
|
How does neuromodulation work.
|
Neurourol Urodyn
|
2011
|
0.80
|
|
79
|
Emerging drugs for the treatment of benign prostatic obstruction.
|
Expert Opin Emerg Drugs
|
2010
|
0.80
|
|
80
|
The future of urology.
|
Eur Urol
|
2011
|
0.79
|
|
81
|
Management of the overactive bladder: a review of pharmacological therapies and methods used by the urological specialist.
|
Can J Urol
|
2007
|
0.79
|
|
82
|
Synthetic vaginal tapes for stress incontinence: proposals for improved regulation of new devices in Europe.
|
Eur Urol
|
2011
|
0.78
|
|
83
|
Ultrasound estimated bladder weight in men attending the uroflowmetry clinic.
|
Neurourol Urodyn
|
2011
|
0.78
|
|
84
|
The long-term natural history of overactive bladder symptoms due to idiopathic detrusor overactivity in women.
|
BJU Int
|
2009
|
0.78
|
|
85
|
Pharmacological management of women with mixed urinary incontinence.
|
Drugs
|
2006
|
0.78
|
|
86
|
The use of ultrasound-estimated bladder weight in diagnosing bladder outlet obstruction and detrusor overactivity in men with lower urinary tract symptoms.
|
Indian J Urol
|
2009
|
0.78
|
|
87
|
The unstable detrusor.
|
Urol Int
|
2004
|
0.78
|
|
88
|
New therapies in the treatment of overactive bladder.
|
Expert Opin Emerg Drugs
|
2013
|
0.78
|
|
89
|
3rd International Consultation on Incontinence--Research Society 2011.
|
Neurourol Urodyn
|
2012
|
0.77
|
|
90
|
Developing a validated urinary diary: phase 1.
|
Neurourol Urodyn
|
2012
|
0.77
|
|
91
|
Future directions in pelvic neuromodulation.
|
Urol Clin North Am
|
2005
|
0.76
|
|
92
|
The impact of formal education and training on urodynamic practice in the United Kingdom: a survey.
|
Neurourol Urodyn
|
2006
|
0.76
|
|
93
|
A simple method for teaching about voiding disorders.
|
BJU Int
|
2006
|
0.75
|
|
94
|
Prevalence of urinary incontinence in women determined using the BFLUTS questionnaire.
|
Neurourol Urodyn
|
2003
|
0.75
|
|
95
|
Nocturia: escaping the "prostate-centric" approach.
|
J Urol
|
2011
|
0.75
|
|
96
|
Editorial comment.
|
J Urol
|
2012
|
0.75
|
|
97
|
Letter to the editor: conflicts of interest.
|
Neurourol Urodyn
|
2008
|
0.75
|
|
98
|
New Medical Education Standards Board will lower standards.
|
BMJ
|
2002
|
0.75
|
|
99
|
Prostate surgery to improve sleep quality: the key to success? (Related to: Hernández C. et al. Nocturia in Spanish patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Curr Med Res Opin 2008 Apr;24(4):1033-8).
|
Curr Med Res Opin
|
2010
|
0.75
|
|
100
|
FAQs: lower urinary tract symptoms in men.
|
Practitioner
|
2004
|
0.75
|
|
101
|
Penile cancer--update.
|
Urology
|
2010
|
0.75
|
|
102
|
Hot and cold technologies for tissue ablation in urology.
|
BJU Int
|
2006
|
0.75
|
|
103
|
Leak point pressures: how useful are they?
|
Curr Opin Urol
|
2015
|
0.75
|
|
104
|
Can we, and do we need to, define bladder neck hypermobility and intrinsic sphincteric deficiency? ICI-RS 2011.
|
Neurourol Urodyn
|
2012
|
0.75
|
|
105
|
The 2nd International Consultation on Incontinence, Research Society (ICI-RS) meeting 2010.
|
Neurourol Urodyn
|
2011
|
0.75
|
|
106
|
Absolute versus relative pressure.
|
Neurourol Urodyn
|
2009
|
0.75
|
|
107
|
Including a 'no active intervention' arm in surgical trials is possible: evidence from the CLasP randomised trial.
|
J Health Serv Res Policy
|
2003
|
0.75
|
|
108
|
Overactive bladder syndrome.
|
Female Pelvic Med Reconstr Surg
|
2010
|
0.75
|
|
109
|
Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom.
|
J Med Econ
|
2013
|
0.75
|
|
110
|
Diagnosis of male incontinence.
|
Curr Opin Urol
|
2013
|
0.75
|